Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,033 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantum simulation of 2D antiferromagnets with hundreds of Rydberg atoms.
Scholl P, Schuler M, Williams HJ, Eberharter AA, Barredo D, Schymik KN, Lienhard V, Henry LP, Lang TC, Lahaye T, Läuchli AM, Browaeys A. Scholl P, et al. Among authors: schuler m. Nature. 2021 Jul;595(7866):233-238. doi: 10.1038/s41586-021-03585-1. Epub 2021 Jul 7. Nature. 2021. PMID: 34234335
Continuous symmetry breaking in a two-dimensional Rydberg array.
Chen C, Bornet G, Bintz M, Emperauger G, Leclerc L, Liu VS, Scholl P, Barredo D, Hauschild J, Chatterjee S, Schuler M, Läuchli AM, Zaletel MP, Lahaye T, Yao NY, Browaeys A. Chen C, et al. Among authors: schuler m. Nature. 2023 Apr;616(7958):691-695. doi: 10.1038/s41586-023-05859-2. Epub 2023 Feb 27. Nature. 2023. PMID: 36848931
68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy.
Lanzafame H, Mavroeidi IA, Pabst KM, Desaulniers M, Ingenwerth M, Hirmas N, Kessler L, Nader M, Bartel T, Leyser S, Barbato F, Schuler M, Bauer S, Siveke JT, Herrmann K, Hamacher R, Fendler WP. Lanzafame H, et al. Among authors: schuler m. J Nucl Med. 2024 May 9:jnumed.123.267248. doi: 10.2967/jnumed.123.267248. Online ahead of print. J Nucl Med. 2024. PMID: 38724279
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.
Schuler M, Cuppens K, Plönes T, Wiesweg M, Du Pont B, Hegedus B, Köster J, Mairinger F, Darwiche K, Paschen A, Maes B, Vanbockrijck M, Lähnemann D, Zhao F, Hautzel H, Theegarten D, Hartemink K, Reis H, Baas P, Schramm A, Aigner C. Schuler M, et al. Nat Med. 2024 Apr 30. doi: 10.1038/s41591-024-02965-0. Online ahead of print. Nat Med. 2024. PMID: 38689060
1,033 results